Anonymous ID: a1aa48 The Bill & Melinda Gates Foundation, Merck & Co., Inc. and the Republic of Botswana Launch New HIV I April 22, 2020, 10:19 a.m. No.8885213   🗄️.is 🔗kun   >>5430 >>5562 >>5780 >>5804

SEATTLE and WHITEHOUSE STATION, N.J. – The Bill & Melinda Gates Foundation, Merck & Co., Inc. and the Republic of Botswana today announced the establishment of the Botswana Comprehensive HIV/AIDS Partnership, a new initiative to improve the overall state of HIV/AIDS care and treatment in Botswana. In collaboration with the government of Botswana, and with an intensive commitment of resources, the Botswana Comprehensive HIV/AIDS Partnership will endeavor to advance significantly HIV/AIDS prevention, healthcare access, patient management and treatment of HIV in Botswana, a country where an estimated 29 percent of the adult population is HIV-positive. The Bill & Melinda Gates Foundation will dedicate $50 million over five years to help Botswana fundamentally strengthen its primary health care system. Merck and The Merck Company Foundation will match the Bill & Melinda Gates Foundation funding through two major components: the development and management of the program and the contribution of antiretroviral medicines. This collaborative program is designed to demonstrate the benefits of a comprehensive approach to improving the care of people living with HIV in a resource-constrained country.

 

"Given the magnitude of the public health challenge we are facing, Botswana welcomes the inauguration of this unique public-private sector partnership," said Joy Phumaphi, Minister of Health of Botswana. "Cooperation and collaboration among all sectors involved in the struggle against HIV/AIDS is essential to the success of practical approaches to preventing and treating HIV infection. The commitment of the Bill & Melinda Gates Foundation and Merck to helping us meet this critical health challenge is encouraging, and we look forward to working with them to improve the health of thousands of people in Botswana living with HIV."

 

Based on initial results, the Bill & Melinda Gates Foundation and Merck will work together with the government of Botswana, global health and development agencies, private sector supporters, donors and other potential sponsors to secure long-term sustainability. Lessons learned from this project will be shared widely throughout the international health and development community to help strengthen the global response to the challenge of HIV/AIDS.

 

https://www.gatesfoundation.org/Media-Center/Press-Releases/2000/07/Comprehensive-HIVAIDS-Partnership

Anonymous ID: a1aa48 April 22, 2020, 10:21 a.m. No.8885235   🗄️.is 🔗kun

Kenneth Carleton Frazier (born December 17, 1954) is an American business executive. He is the chairman and CEO of the pharmaceutical company Merck & Co. (known as MSD outside of North America). After joining Merck & Co. as general counsel, he directed the company's defense against litigation over the anti-inflammatory drug Vioxx. Frazier is the first black man to lead a major pharmaceutical company (part of the Fortune 500 companies).[1] He was elected to the American Philosophical Society in 2018